Johnson & Johnson submitted an application for drug indication extension to the European Medicines Agency.
1 report, 0 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson submitted an application for drug indication extension to the European Medicines Agency.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- J&J's Darzalex received regulatory approval in Europe and the United States following review of TRIANGLE study data.Sub-event
- J&J submitted an application for drug indication extension to the EMA.
Keep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet